Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 54.79B | 55.73B | 55.88B | 50.22B | 44.79B | 43.07B |
Gross Profit | 13.83B | 14.81B | 12.98B | 11.64B | 9.86B | 10.30B |
EBITDA | 6.67B | 6.76B | 5.66B | 5.07B | 3.62B | 4.42B |
Net Income | 3.83B | 3.96B | 3.29B | 2.54B | 1.89B | 2.31B |
Balance Sheet | ||||||
Total Assets | 48.55B | 50.94B | 54.03B | 47.90B | 41.45B | 40.03B |
Cash, Cash Equivalents and Short-Term Investments | 8.19B | 10.21B | 6.32B | 5.40B | 5.55B | 4.52B |
Total Debt | 5.72B | 5.36B | 8.29B | 7.37B | 7.39B | 7.16B |
Total Liabilities | 19.03B | 20.42B | 26.98B | 24.55B | 21.75B | 21.05B |
Stockholders Equity | 24.61B | 25.63B | 22.25B | 19.07B | 17.60B | 16.16B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 7.67B | 680.79M | -697.79M | 2.00B | 4.44B |
Operating Cash Flow | 0.00 | 8.94B | 1.15B | 120.19M | 3.17B | 5.10B |
Investing Cash Flow | 0.00 | -1.02B | -330.72M | -1.73B | -2.07B | -505.09M |
Financing Cash Flow | 0.00 | -3.36B | 76.30M | 15.76M | -100.30M | -3.76B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥35.99B | 8.70 | 1.56% | -0.27% | 22.35% | ||
77 Outperform | ¥14.40B | 20.36 | 2.93% | 11.76% | 9.90% | ||
75 Outperform | ¥132.69B | 16.43 | 1.41% | 7.59% | -4.36% | ||
74 Outperform | ¥220.71B | 19.48 | 2.51% | 12.84% | 54.25% | ||
69 Neutral | ¥33.89B | 9.46 | 2.58% | 9.40% | -32.82% | ||
67 Neutral | ¥3.17B | 12.37 | 5.31% | 1.87% | -33.27% | ||
65 Neutral | $10.75B | 15.72 | 5.20% | 1.90% | 3.09% | -27.42% |